Clinical variable | Study number | Rebleed | Mortality | ||
---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | ||
Hemoglobin (mean or median) | |||||
< 8.0 | 3c,d,e | 1.495 (0.694–3.219) | 0.305 | 1.458 (0.545–3.897) | 0.452 |
≥ 8.0 | 2a,b | 3.642 (1.491–8.895) | 0.005 | 8.77 (3.344–22.997) | < 0.001 |
Percentage of NSAID use (excluding aspirin) | |||||
≥ 20% | 2c,d | 2.83 (0.91–8.87) | 0.074 | 8.0 (1.753–36.512) | 0.007 |
< 20% | 2a,b | 1.49 (0.69–3.22) | 0.305 | 1.458 (0.545–3.897) | 0.452 |
Follow-up | |||||
30-day | 3a,b,c | 1.816 (0.896–3.683) | 0.098 | 2.209 (0.94–5.192) | 0.069 |
NS | 2d,e | 3.394 (1.268–9.082) | 0.015 | 8.981 (3.05–26.439) | < 0.001 |